StockData
DuPont de Nemours, Inc. logo

DuPont de Nemours, Inc. (DD) stock analysis

DDNYSEPlastic Materials, Synth Resins & Nonvulcan ElastomersFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3059% above fair value
$156.88+1.74 (+1.12%)

Close on Nov 10, 2026Market cap $21.19BP/E 348.6Yield 2.73%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth2Performance0Health4Dividend2

Weak8 of 30 checks passed

DuPont de Nemours passes 8 of the 30 checks behind our score; 5 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
2/6
Past performance
0/6
Financial health
4/6
Dividend
2/6

What stands out

  • Low debt

    Debt is 22.7% of shareholders' equity, under the 40% we consider low.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 33.3% of total debt.

  • Guidance raised

    DuPont de Nemours raised its Full Year 2026E Adjusted EPS outlook on Nov 3, 2026.

  • Covered by free cash flow

    Dividends take 59.4% of free cash flow.

What to watch

  • Margin of safety under 20%

    The price is 59.5% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $156.88 is above our fair value estimate of $98.38.

  • Return on equity under 15%

    Return on equity was 0.3% over the last twelve months and averaged 8.5% over five years; we look for 15% on both.

  • Revenue growing under 10% a year

    Revenue grew -19.3% a year over the last three fiscal years, short of the 10% we look for.

Valuation0/6
  • P/E above its 5-year median

    DuPont de Nemours's P/E of 348.6 is above its own 5-year median of 19.0.

  • P/E above the industry

    DuPont de Nemours's P/E of 348.6 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA above its 5-year median

    DuPont de Nemours's EV/EBITDA of 24.8 is above its 5-year median of 20.3.

  • P/B above the industry

    DuPont de Nemours's price-to-book of 1.54 is above the Chemicals and Allied Products median of 1.50.

  • Trading above fair value

    The share price of $156.88 is above our fair value estimate of $98.38.

  • Margin of safety under 20%

    The price is 59.5% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew -19.3% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 3.3% over the last twelve months; the Chemicals and Allied Products median is 5.7%.

  • Guidance raised

    DuPont de Nemours raised its Full Year 2026E Adjusted EPS outlook on Nov 3, 2026.

  • Gross margin improving

    Gross margin was 35.1% over the last twelve months, against 33.7% a year earlier.

Past performance0/6
  • Return on equity under 15%

    Return on equity was 0.3% over the last twelve months and averaged 8.5% over five years; we look for 15% on both.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity below the industry

    DuPont de Nemours's return on equity of 0.3% is below the Chemicals and Allied Products median of 3.7%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was 0.8% over the last twelve months, against a 5-year average of 20.4%.

  • Net margin below the industry

    DuPont de Nemours's net margin of 0.8% is below the Chemicals and Allied Products median of 0.8%.

Financial health4/6
  • Low debt

    Debt is 22.7% of shareholders' equity, under the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 40.5% five years ago to 22.7%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 33.3% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 2.43 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.65; above 3 is the safe zone and below 1.8 the distress zone.

Dividend2/6
  • Pays a dividend

    DuPont de Nemours paid dividends worth 1.5% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.5% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; DuPont de Nemours yields 1.5%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Not covered by earnings

    Dividends take 758% of net income, leaving little room.

  • Covered by free cash flow

    Dividends take 59.4% of free cash flow.

Scores of similar companies

Our estimate per share

$98.38

The share price is 59% above this estimate.

20%+ below
Near fair value
20%+ above
$156.88Price$98.38Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/Eleft out, too far from the others22.1×19.0×25.2×$9.94–
EV/EBITDA18.4×20.3×16.6×$114.4258%
P/B1.4×1.4×1.5×$146.1517%
Earnings power10.6% cost of equity––$29.1025%
Fair value$98.38100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 19.0
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$144.00M
Value traded per 1% price move
$114.83M

Downside

Low risk

Typical loss in a bad month
12.7%
Volatility (annualized)
30%
Sharpe ratio, 1 year
0.89
Beta to the S&P 500 (5Y)
1.14

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2014 to 2025

Gross margin

34.5%−2.0 pts over 5 years

Net margin

-11.4%+15.1 pts over 5 years

See a number that looks wrong?